Labeled Schwann cell transplantation: cell loss, host Schwann cell replacement, and strategies to enhance survival.

scientific article published on February 2006

Labeled Schwann cell transplantation: cell loss, host Schwann cell replacement, and strategies to enhance survival. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/GLIA.20287
P8608Fatcat IDrelease_fkswtrhxunbapaw6o5wtg4z7li
P698PubMed publication ID16267833
P5875ResearchGate publication ID7499914

P50authorLawrence MoonQ58232906
P2093author name stringMary Bartlett Bunge
Patrick M Wood
Caitlin E Hill
P2860cites workTransient immunosuppression stops rejection of virus-transduced enhanced green fluorescent protein in rabbit retina.Q40161594
Peripheral olfactory ensheathing cells reduce scar and cavity formation and promote regeneration after spinal cord injuryQ44832747
Viral vector-mediated gene expression in olfactory ensheathing glia implants in the lesioned rat spinal cord.Q45883608
BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injuryQ46052857
Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord.Q48525862
Use of a rat Y chromosome probe to determine the long-term survival of glial cells transplanted into areas of CNS demyelinationQ48735273
Schwann cells transplanted into normal and X-irradiated adult white matter do not migrate extensively and show poor long-term survival.Q50510445
Ubiquitous expression of marker transgenes in mice and rats.Q52174452
Temporal–Spatial Pattern of Acute Neuronal and Glial Loss after Spinal Cord ContusionQ59468421
Effects of Schwann cell transplantation in a contusion model of rat spinal cord injuryQ71694664
Acute transplantation of glial-restricted precursor cells into spinal cord contusion injuries: survival, differentiation, and effects on lesion environment and axonal regenerationQ80973434
P433issue3
P921main subjectSchwann cellQ465621
P304page(s)338-343
P577publication date2006-02-01
P1433published inGliaQ15716658
P1476titleLabeled Schwann cell transplantation: cell loss, host Schwann cell replacement, and strategies to enhance survival
P478volume53

Reverse relations

cites work (P2860)
Q3759531317β-estradiol protects human eyelid-derived adipose stem cells against cytotoxicity and increases transplanted cell survival in spinal cord injury
Q34254821A calpain inhibitor enhances the survival of Schwann cells in vitro and after transplantation into the injured spinal cord
Q35127777A systematic review of cellular transplantation therapies for spinal cord injury
Q35809691An overview of tissue engineering approaches for management of spinal cord injuries
Q28475604Analysis of host-mediated repair mechanisms after human CNS-stem cell transplantation for spinal cord injury: correlation of engraftment with recovery
Q38616866Attenuation of Oxidative Stress-Induced Cell Apoptosis in Schwann RSC96 Cells by Ocimum Gratissimum Aqueous Extract
Q35071889Biphasic bisperoxovanadium administration and Schwann cell transplantation for repair after cervical contusive spinal cord injury.
Q41851504Breaking news in spinal cord injury research: FDA approved phase I clinical trial of human, autologous schwann cell transplantation in patients with spinal cord injuries
Q39261219Cell transplantation therapy for spinal cord injury.
Q36956709Cellular approaches for stimulating CNS remyelination
Q24630772Cellular treatments for spinal cord injury: the time is right for clinical trials
Q37476168Combinatorial strategies with Schwann cell transplantation to improve repair of the injured spinal cord
Q53410201Combined effects of rat Schwann cells and 17β-estradiol in a spinal cord injury model.
Q26861926Current concept in neural regeneration research: NSCs isolation, characterization and transplantation in various neurodegenerative diseases and stroke: A review
Q89179338Decellularized peripheral nerve supports Schwann cell transplants and axon growth following spinal cord injury
Q36227419Differential effects of distinct central nervous system regions on cell migration and axonal extension of neural precursor transplants
Q38809907Does the preclinical evidence for functional remyelination following myelinating cell engraftment into the injured spinal cord support progression to clinical trials?
Q57997786Efficient Generation of Schwann Cells from Human Embryonic Stem Cell-Derived Neurospheres
Q36464568Fabrication of growth factor- and extracellular matrix-loaded, gelatin-based scaffolds and their biocompatibility with Schwann cells and dorsal root ganglia
Q54654209Functional and Histological Improvement of the Injured Spinal Cord Following Transplantation of Schwann Cells Transfected With NRG1 Gene
Q41016467Grafted Activated Schwann Cells Support Survival of Injured Rat Spinal Cord White Matter.
Q47876397Human Schwann cells exhibit long-term cell survival, are not tumorigenic and promote repair when transplanted into the contused spinal cord
Q35737471Human Schwann cells retain essential phenotype characteristics after immortalization
Q38784001Human dental pulp stem cells expressing STRO-1, c-kit and CD34 markers in peripheral nerve regeneration.
Q37664162Human olfactory mesenchymal stromal cell transplants promote remyelination and earlier improvement in gait co-ordination after spinal cord injury.
Q34385587Long-term survival, axonal growth-promotion, and myelination of Schwann cells grafted into contused spinal cord in adult rats
Q27312623MASH1/Ascl1a leads to GAP43 expression and axon regeneration in the adult CNS
Q55111012Macrophage depletion and Schwann cell transplantation reduce cyst size after rat contusive spinal cord injury.
Q37134181Morphological characteristics of apoptosis and its significance in neurogenesis
Q35613352Multifunctional, multichannel bridges that deliver neurotrophin encoding lentivirus for regeneration following spinal cord injury
Q37471457Multiple channel bridges for spinal cord injury: cellular characterization of host response.
Q26797407Myelin damage and repair in pathologic CNS: challenges and prospects
Q48172017Myelinogenic Plasticity of Oligodendrocyte Precursor Cells following Spinal Cord Contusion Injury
Q47980734Noninvasive bioluminescence imaging of olfactory ensheathing glia and schwann cells following transplantation into the lesioned rat spinal cord
Q36932263Novel combination strategies to repair the injured mammalian spinal cord.
Q46775449Olfactory ensheathing cells do not exhibit unique migratory or axonal growth-promoting properties after spinal cord injury.
Q37299595P2X7 purinoceptors contribute to the death of Schwann cells transplanted into the spinal cord
Q28071648Peripheral Nerve Injury: Stem Cell Therapy and Peripheral Nerve Transfer
Q52626491Peripheral nerve repair with cultured schwann cells: getting closer to the clinics.
Q57816233Polycaprolactone electrospun fiber scaffold loaded with iPSCs-NSCs and ASCs as a novel tissue engineering scaffold for the treatment of spinal cord injury
Q83292612Promoting survival, migration, and integration of transplanted Schwann cells by over-expressing polysialic acid
Q90738658Recent advances in nanotherapeutic strategies for spinal cord injury repair
Q64981683Regeneration of Spinal Cord Connectivity Through Stem Cell Transplantation and Biomaterial Scaffolds.
Q37227963Resection of glial scar following spinal cord injury
Q38247993Role of endogenous Schwann cells in tissue repair after spinal cord injury
Q92240715Schwann Cell-Like Cells Derived from Human Amniotic Mesenchymal Stem Cells Promote Peripheral Nerve Regeneration through a MicroRNA-214/c-Jun Pathway
Q36858361Schwann cell coculture improves the therapeutic effect of bone marrow stromal cells on recovery in spinal cord-injured mice.
Q83475978Schwann cell plasticity after spinal cord injury shown by neural crest lineage tracing
Q53476981Schwann cell precursors transplanted into the injured spinal cord multiply, integrate and are permissive for axon growth.
Q50683619Schwann cell transplantation improves reticulospinal axon growth and forelimb strength after severe cervical spinal cord contusion.
Q48193521Schwann cells generated from neonatal skin-derived precursors or neonatal peripheral nerve improve functional recovery after acute transplantation into the partially injured cervical spinal cord of the rat.
Q28743246Schwann-spheres derived from injured peripheral nerves in adult mice--their in vitro characterization and therapeutic potential
Q34679913Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury.
Q34206417The MMP-9/TIMP-1 axis controls the status of differentiation and function of myelin-forming Schwann cells in nerve regeneration
Q36337994The assessment of adeno-associated vectors as potential intrinsic treatments for brainstem axon regeneration
Q55449341The role of undifferentiated adipose-derived stem cells in peripheral nerve repair.
Q36542728Therapeutic interventions after spinal cord injury.
Q30558579Tissue sparing, behavioral recovery, supraspinal axonal sparing/regeneration following sub-acute glial transplantation in a model of spinal cord contusion
Q52652656Transplantation of Adult Rat Schwann Cells into the Injured Spinal Cord.
Q48155979Transplantation of Schwann cells and/or olfactory ensheathing glia into the contused spinal cord: Survival, migration, axon association, and functional recovery
Q37619428Transplantation of neural progenitor cells in chronic spinal cord injury
Q57838429Traumatic spinal cord injury
Q53079504White matter repair: skin-derived precursors as a source of myelinating cells.
Q37876560Will stem cell therapies be safe and effective for treating spinal cord injuries?
Q28087189iPS cell transplantation for traumatic spinal cord injury

Search more.